» Articles » PMID: 34932890

Body Composition and Cardiometabolic Health Across the Menopause Transition

Overview
Date 2021 Dec 21
PMID 34932890
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Every year, 2 million women reach menopause in the United States, and they may spend 40% or more of their life in a postmenopausal state. In the years immediately preceding menopause-known as the menopause transition (or perimenopause)-changes in hormones and body composition increase a woman's overall cardiometabolic risk. In this narrative review, we summarize the changes in weight, body composition, and body fat distribution, as well as the changes in energy intake, energy expenditure, and other cardiometabolic risk factors (lipid profile, glucose metabolism, sleep health, and vascular function), that occur during the menopause transition. We also discuss the benefits of lifestyle interventions in women in the earlier stages of menopause before these detrimental changes occur. Finally, we discuss how to include perimenopausal women in research studies so that women across the life-span are adequately represented.

Citing Articles

Effects of physical exercise on the lipid profile of perimenopausal and postmenopausal women: a systematic review and meta-analysis.

Bernal J, Sanchez-Delgado J, Jacome-Hortua A, Veiga A, Andrade G, Rodrigues M Braz J Med Biol Res. 2025; 58:e14194.

PMID: 40053039 PMC: 11884766. DOI: 10.1590/1414-431X2025e14194.


Association of Kidney Function With 10-Year Risk of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Its Risk Factors Among Women With Type 2 Diabetes Mellitus.

Siddiqui K, George T, Mujammami M, Alfadda A, Nawaz S, Rafiullah M Int J Womens Health. 2025; 17:449-457.

PMID: 39990930 PMC: 11846610. DOI: 10.2147/IJWH.S485470.


Association between sarcopenia and cardiovascular disease according to menopausal status: findings from the China Health and Retirement Longitudinal Study (CHARLS).

Dai X, He S, Wu Y, Zhuang J, Xu G BMC Public Health. 2025; 25(1):730.

PMID: 39987043 PMC: 11846386. DOI: 10.1186/s12889-025-21933-y.


Analysis of Exosomal miRNA and Hepatic mRNA Expression in the Dysregulation of Insulin Action in Perimenopausal Mice.

Yang Y, Chen Y, Liu C, Wang S, Zhao Y, Cao W J Diabetes Res. 2025; 2025():6251747.

PMID: 39823117 PMC: 11737908. DOI: 10.1155/jdr/6251747.


Functional Foods and Nutraceuticals for the Management of Cardiovascular Disease Risk in Postmenopausal Women.

Meegaswatte H, Speer K, McKune A, Naumovski N Rev Cardiovasc Med. 2025; 25(12):460.

PMID: 39742223 PMC: 11683719. DOI: 10.31083/j.rcm2512460.


References
1.
Stuenkel C, Davis S, Gompel A, Lumsden M, Murad M, Pinkerton J . Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(11):3975-4011. DOI: 10.1210/jc.2015-2236. View

2.
Liu P, Ji Y, Yuen T, Rendina-Ruedy E, DeMambro V, Dhawan S . Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017; 546(7656):107-112. PMC: 5651981. DOI: 10.1038/nature22342. View

3.
Blew R, Sardinha L, Milliken L, Teixeira P, Going S, Ferreira D . Assessing the validity of body mass index standards in early postmenopausal women. Obes Res. 2002; 10(8):799-808. DOI: 10.1038/oby.2002.108. View

4.
Ravussin E, Lillioja S, Knowler W, Christin L, Freymond D, Abbott W . Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988; 318(8):467-72. DOI: 10.1056/NEJM198802253180802. View

5.
Kelemen M, Vaidya D, Waters D, Howard B, Cobb F, Younes N . Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis. 2005; 179(1):193-200. DOI: 10.1016/j.atherosclerosis.2004.09.021. View